Kantonsspital St.Gallen
login

PIONEER REAL

Stefan Bilz, Tilman Drescher, Victoria Grillmayr & Andrea Räss

abstract

The primary objective is to investigate the glycaemic control in adult
patients with type 2 diabetes (T2D) who have not previously been
treated with injectable glucose-lowering medication and who initiate
treatment with oral semaglutide according to local clinical practice.

The secondary objective is to investigate mean change in body
weight in adult patients with T2D who have not previously been
treated with injectable glucose-lowering medication and who initiate
treatment with oral semaglutide according to local clinical practice.
   
type of project clinical studies
status ongoing - recruiting phase
start of project 2020
end of project 2022
study design A multi-centre, prospective, non-interventional single-arm
study investigating clinical parameters associated with the
use of once-daily oral semaglutide in a real-world adult
population with type 2 diabetes in Switzerland
responsible person Stefan Bilz